Variant report
Variant | nsv1043316 |
---|---|
Chromosome Location | chr11:5847076-5887925 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:60)
- CpG islands (count:305)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr11:5867958-5868232 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr11:5872999-5873041 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr11:5860791-5861085 | HepG2 | liver: | n/a | chr11:5860903-5860914 chr11:5861009-5861022 |
4 | CEBPB | chr11:5872262-5872604 | IMR90 | lung: | n/a | n/a |
5 | CEBPB | chr11:5872256-5872635 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr11:5872237-5872619 | K562 | blood: | n/a | n/a |
7 | CEBPB | chr11:5872324-5872546 | K562 | blood: | n/a | n/a |
8 | CEBPB | chr11:5872276-5872519 | HepG2 | liver: | n/a | n/a |
9 | CEBPB | chr11:5872283-5872577 | A549 | lung: | n/a | n/a |
10 | CEBPB | chr11:5872260-5872623 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | CTCF | chr11:5881260-5881410 | K562 | blood: | n/a | n/a |
12 | CTCF | chr11:5851940-5852090 | HRE | kidney: | n/a | n/a |
13 | CTCF | chr11:5857183-5857254 | Lung_OC | lung: | n/a | n/a |
14 | CUX1 | chr11:5885690-5885712 | GM12878 | blood: | n/a | n/a |
15 | CUX1 | chr11:5868005-5868222 | K562 | blood: | n/a | n/a |
16 | E2F4 | chr11:5860873-5861214 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | EBF1 | chr11:5852617-5852788 | GM12878 | blood: | n/a | chr11:5852704-5852715 |
18 | EBF1 | chr11:5852638-5852851 | GM12878 | blood: | n/a | chr11:5852704-5852715 |
19 | FOS | chr11:5859495-5859695 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOS | chr11:5866203-5866313 | MCF10A-Er-Src | breast: | n/a | chr11:5866270-5866279 |
21 | FOS | chr11:5859472-5859773 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | FOS | chr11:5859481-5859658 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr11:5859452-5859761 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | GATA2 | chr11:5867938-5868231 | K562 | blood: | n/a | n/a |
25 | GATA3 | chr11:5866686-5866880 | SH-SY5Y | brain: | n/a | chr11:5866736-5866746 |
26 | JUND | chr11:5859569-5859657 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | NFYA | chr11:5861168-5861251 | GM12878 | blood: | n/a | n/a |
28 | NFYA | chr11:5871139-5871260 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr11:5855986-5855998 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr11:5869476-5869551 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr11:5850552-5850687 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr11:5869992-5870192 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr11:5874795-5874859 | GM12878 | blood: | n/a | n/a |
34 | POLR2A | chr11:5875602-5875721 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | POLR2A | chr11:5861122-5861243 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | POLR2A | chr11:5849167-5849190 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr11:5887368-5887448 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr11:5858691-5859058 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr11:5858673-5858678 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | POLR2A | chr11:5882397-5882439 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | POLR2A | chr11:5881104-5881191 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | RCOR1 | chr11:5870763-5870771 | GM12878 | blood: | n/a | n/a |
43 | SPI1 | chr11:5875635-5875791 | K562 | blood: | n/a | n/a |
44 | SPI1 | chr11:5875526-5875870 | HL-60 | blood: | n/a | n/a |
45 | SPI1 | chr11:5875626-5875733 | GM12878 | blood: | n/a | n/a |
46 | SPI1 | chr11:5875598-5875807 | GM12891 | blood: | n/a | n/a |
47 | STAT3 | chr11:5885927-5886104 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | STAT3 | chr11:5849342-5849689 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | STAT3 | chr11:5859566-5859666 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | STAT3 | chr11:5855544-5855726 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:5878958-5879008 | HRE | kidney: | n/a |
2 | chr11:5878955-5879005 | HUVEC | blood vessel: | n/a |
3 | chr11:5862757-5862807 | RPTEC | kidney: | n/a |
4 | chr11:5862757-5862807 | LNCaP | prostate: | n/a |
5 | chr11:5878958-5879008 | NT2-D1 | testis: | n/a |
6 | chr11:5862757-5862807 | SAEC | small airway: | n/a |
7 | chr11:5862757-5862807 | HMEC | breast: | n/a |
8 | chr11:5878958-5879008 | HMEC | breast: | n/a |
9 | chr11:5878958-5879008 | HUVEC | blood vessel: | n/a |
10 | chr11:5862757-5862807 | Jurkat | blood: | n/a |
11 | chr11:5878958-5879008 | HCF | heart: | n/a |
12 | chr11:5878019-5878069 | HRPEpiC | eye: | n/a |
13 | chr11:5879799-5879849 | NB4 | blood: | n/a |
14 | chr11:5878958-5879008 | A549 | lung: | n/a |
15 | chr11:5878958-5879008 | GM12891 | blood: | n/a |
16 | chr11:5878955-5879005 | PFSK-1 | brain: | n/a |
17 | chr11:5878955-5879005 | GM12878 | blood: | n/a |
18 | chr11:5878958-5879008 | PANC-1 | pancreas: | n/a |
19 | chr11:5862757-5862807 | HepG2 | liver: | n/a |
20 | chr11:5878955-5879005 | HCF | heart: | n/a |
21 | chr11:5879799-5879849 | MCF-7 | breast: | n/a |
22 | chr11:5862757-5862807 | Hepatocyte | liver: | n/a |
23 | chr11:5878019-5878069 | ovcar-3 | ovarian: | n/a |
24 | chr11:5878019-5878069 | ProgFib | skin: | n/a |
25 | chr11:5878019-5878069 | HNPCEpiC | eye: | n/a |
26 | chr11:5862757-5862807 | HNPCEpiC | eye: | n/a |
27 | chr11:5878955-5879005 | HCM | heart: | n/a |
28 | chr11:5878958-5879008 | IMR90 | lung: | fetal |
29 | chr11:5878955-5879005 | GM19239 | blood: | n/a |
30 | chr11:5862757-5862807 | MCF10A-Er-Src | breast: | n/a |
31 | chr11:5879799-5879849 | BJ | skin: | n/a |
32 | chr11:5862757-5862807 | HPAEpiC | pulmonary alveolar: | n/a |
33 | chr11:5878958-5879008 | BE2_C | brain: | n/a |
34 | chr11:5878019-5878069 | HepG2 | liver: | n/a |
35 | chr11:5878019-5878069 | T-47D | breast: | n/a |
36 | chr11:5878955-5879005 | PrEC | prostate: | n/a |
37 | chr11:5878019-5878069 | HEEpiC | esophagus: | n/a |
38 | chr11:5878958-5879008 | HNPCEpiC | eye: | n/a |
39 | chr11:5862757-5862807 | HIPEpiC | eye: | n/a |
40 | chr11:5862757-5862807 | NB4 | blood: | n/a |
41 | chr11:5878019-5878069 | AG09309 | skin: | n/a |
42 | chr11:5878958-5879008 | LNCaP | prostate: | n/a |
43 | chr11:5862757-5862807 | Hela-S3 | cervix: | n/a |
44 | chr11:5879799-5879849 | AG04450 | lung: | fetal |
45 | chr11:5879799-5879849 | SK-N-SH | brain: | n/a |
46 | chr11:5878958-5879008 | SK-N-SH | brain: | n/a |
47 | chr11:5879799-5879849 | Caco-2 | colon: | n/a |
48 | chr11:5878955-5879005 | AG09309 | skin: | n/a |
49 | chr11:5878958-5879008 | GM12878 | blood: | n/a |
50 | chr11:5862757-5862807 | PrEC | prostate: | n/a |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR52E6 | TF binding region |
OR52E8 | TF binding region |
OR52E6 | CpG island |
OR52E8 | CpG island |
ENSG00000233563 | chromatin interactions |
ENSG00000132256 | chromatin interactions |
ENSG00000121236 | chromatin interactions |
ENSG00000183269 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs36003226 | chr11:5847644-5847645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541370251 | chr11:5847665-5847666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189338140 | chr11:5847692-5847693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574450599 | chr11:5847783-5847784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11039187 | chr11:5847858-5847859 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs11039188 | chr11:5847863-5847864 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs35586544 | chr11:5847903-5847904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181399634 | chr11:5847924-5847925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536552959 | chr11:5847955-5847956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs61875935 | chr11:5847961-5847962 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs565474267 | chr11:5847962-5847963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs207471637 | chr11:5847968-5847969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61875936 | chr11:5847972-5847973 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs547472505 | chr11:5847973-5847974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185236792 | chr11:5847996-5847997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7943035 | chr11:5848021-5848022 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs544225293 | chr11:5848037-5848038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548182169 | chr11:5848069-5848070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569811276 | chr11:5848096-5848097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557724656 | chr11:5848119-5848120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537349040 | chr11:5848123-5848124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558605426 | chr11:5848125-5848126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112689227 | chr11:5848134-5848135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189741966 | chr11:5848135-5848136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534826096 | chr11:5848143-5848144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs137960457 | chr11:5848180-5848181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181396563 | chr11:5848226-5848227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186033225 | chr11:5848248-5848249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190021163 | chr11:5848264-5848265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575199530 | chr11:5848277-5848278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544074584 | chr11:5848292-5848293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565477012 | chr11:5848302-5848303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532707275 | chr11:5848303-5848304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181907832 | chr11:5848341-5848342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370315338 | chr11:5848454-5848455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs559376110 | chr11:5848460-5848461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530143715 | chr11:5848487-5848488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560612389 | chr11:5848508-5848509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548315970 | chr11:5848515-5848516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186286864 | chr11:5848538-5848539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs140929965 | chr11:5848583-5848584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560741022 | chr11:5848584-5848585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552412144 | chr11:5848591-5848592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570675125 | chr11:5848607-5848608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144581717 | chr11:5848611-5848612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529437243 | chr11:5848637-5848638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553210308 | chr11:5848655-5848656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs370006101 | chr11:5848661-5848662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568300202 | chr11:5848669-5848670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191064512 | chr11:5848683-5848684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 23613489 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ependymoma | 20639864 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:5847600-5847800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr11:5847600-5848000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr11:5847800-5852600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr11:5851800-5852800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr11:5852200-5852800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr11:5852200-5853400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr11:5852200-5853400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr11:5852400-5852800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr11:5852400-5853200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr11:5852400-5853400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr11:5852400-5853400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr11:5852600-5853000 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr11:5852600-5853200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
14 | chr11:5852800-5853200 | Enhancers | Adipose Nuclei | Adipose |
15 | chr11:5853000-5853400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr11:5862200-5863000 | Active TSS | Brain Substantia Nigra | brain |
17 | chr11:5867400-5869000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
18 | chr11:5867800-5868400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr11:5867800-5868400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr11:5868400-5869000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
21 | chr11:5869000-5869200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
22 | chr11:5869000-5869800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
23 | chr11:5869800-5870000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |